13F-HR filed by TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 89 holding rows worth $688,313,808.
- Accession
- 0001214659-23-002405
- Filer
- CIK 1232621
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 89 entries on the cover page, a total value of $688,313,808 stated on the cover page (in dollars after the unit check, H1), rows summing to $688,313,808 with VALUE read as dollars as filed, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTANG KEVIN C028-14818
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANAPTYSBIO INC | 032724106 | COM | 2,628,678 | $81,462,731 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 2,700,450 | $44,422,403 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 4,635,528 | $32,077,854 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,001,585 | $29,343,236 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 3,124,076 | $25,773,627 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 105,000 | $24,953,250 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 320,000 | $24,681,600 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 405,600 | $23,147,592 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,120,000 | $21,840,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 3,196,446 | $21,607,975 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 692,925 | $20,240,339 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 85,000 | $18,694,900 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,450,000 | $16,646,000 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 281,200 | $15,494,120 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 300,000 | $14,385,000 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 80,000 | $14,369,600 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 240,000 | $12,700,800 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 170,000 | $11,526,000 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,870,000 | $11,201,300 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 3,755,934 | $9,389,835 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 200,000 | $9,304,000 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 600,000 | $8,988,000 | dollars as filed | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 411,968 | $8,902,628 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 21,000 | $8,830,290 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 809,231 | $8,537,387 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 200,000 | $7,554,000 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 20,000 | $7,316,800 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,700,000 | $7,310,000 | dollars as filed | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 1,150,000 | $6,716,000 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,274,853 | $6,323,271 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 809,488 | $6,079,255 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,510,445 | $5,616,712 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 600,000 | $5,364,000 | dollars as filed | |
| GENFIT S A | 372279109 | ADS | 1,197,522 | $5,255,924 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 114,950 | $5,101,481 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 110,000 | $5,040,200 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 3,470,700 | $4,650,738 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 30,000 | $4,506,600 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 36,090 | $4,407,672 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 50,000 | $4,404,500 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 216,700 | $4,232,151 | dollars as filed | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 392,500 | $3,917,150 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 447,967 | $3,771,882 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 95,000 | $3,715,450 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 100,000 | $3,695,000 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 1,100,000 | $3,652,000 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 409,463 | $3,492,719 | dollars as filed | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 118,857 | $3,474,190 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 166,203 | $3,320,736 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 300,000 | $3,192,000 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 400,000 | $3,144,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 147,920 | $3,058,986 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 60,000 | $2,995,200 | dollars as filed | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 2,738,947 | $2,735,660 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 60,000 | $2,718,600 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 2,816,391 | $2,683,739 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 245,714 | $2,579,997 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 250,000 | $2,342,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 140,000 | $1,943,200 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 5,364,925 | $1,931,373 | dollars as filed | |
| METACRINE INC | 59101E103 | COM | 4,250,000 | $1,903,575 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 272,293 | $1,895,159 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 300,000 | $1,803,000 | dollars as filed | |
| TONIX PHARMACEUTICALS HOLDIN | 890260862 | Common Stock | 4,500,419 | $1,754,263 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 40,000 | $1,752,400 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 485,234 | $1,538,192 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 30,000 | $1,026,300 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 21,192 | $944,527 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 115,900 | $917,928 | dollars as filed | |
| SIO GENE THERAPIES INC | 829399104 | COM | 2,000,000 | $870,000 | dollars as filed | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 200,000 | $864,000 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 514,655 | $797,715 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 318,926 | $781,369 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 2,000,000 | $742,000 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 400,000 | $520,000 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 479,854 | $455,861 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 195,000 | $440,700 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 10,000 | $406,500 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 164,190 | $371,069 | dollars as filed | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 429,647 | $352,311 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 100,000 | $349,000 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 123,430 | $270,312 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 100,000 | $217,000 | dollars as filed | |
| MOLECULAR PARTNERS AG | 60853G106 | ADS | 22,000 | $144,100 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 101,762 | $103,797 | dollars as filed | |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 24,125 | $102,531 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 59,600 | $97,744 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 30,587 | $71,268 | dollars as filed | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 33,748 | $57,034 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-23-002405 | this filing | 2023-02-14 | acceptance time not in the bulk data set |